Refoxy Pharma is a promising player in the biotechnology sector, established in 2020 and headquartered in Germany. The company's slogan "Discovering medicines to treat age-related diseases and extend the years of healthy living" emphasizes its focus on developing innovative treatments for aging and aging-associated diseases. Refoxy Pharma is currently in the pre-clinical stage, dedicated to the development of groundbreaking medicines aimed at extending healthy life years. The recent Seed Round investment in August 2021 comes from Korify Capital, signaling a growing interest in the company's potential within the pharmaceutical and manufacturing industries. With a strong emphasis on age-related disease therapeutics, Refoxy Pharma has the potential to make a significant impact on the healthcare landscape and attract further investment in the future.
No recent news or press coverage available for Refoxy Pharma.